Camizestrant CAS 2222844-89-3

Deskripsyon Product:

Non pwodwi: Camizestrant CAS 2222844-89-3

 

Sinonim:

N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo[4,5-f]izoquinolin-6-yl]pyridin-3-amine

Antagonist reseptè estwojèn 2

 

 

Pwopriyete Chimik ak Fizik

Aparans: Off-blan rive jòn limyè Solid

Esè: NLT98%

Pwen bouyi: 590.2 degre (lit.)

Dansite: 1.318g / cm3

pKa:14.25

 

 

Aplikasyon:

Camizestrant (kod devlopman AZD9833, non komèsyal Etcamah) se yon pwochen -jenerasyon oral selektif reseptè estwojèn degrader (SERD) ak antagonist reseptè estwojèn konplè devlope pa AstraZeneca.

 

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: camizestrant cas 2222844-89-3, manifaktirè, founisè, faktori, achte, nan stock

• On: Ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS 1206124-13-1
• Pwochen: (S)-3-(4-bromothiazole-2-yl)-2-((tètbutyloxycarbonyl)amino)propanoik Asidmethyl Ester CAS 2641451-73-0